# Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide

> **NCT04231084** · PHASE4 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 115 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** Vasodilator testing (Inhaled Nitric Oxide)
- **DRUG:** Vasodilator testing (Inhaled Epoprostenol)

## Key facts

- **NCT ID:** NCT04231084
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-15
- **Primary completion:** 2024-08-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04231084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04231084, "Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04231084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*